< Back to front page Text size +

Today's Globe: testing the water, second opinion

Posted by Elizabeth Cooney January 5, 2009 06:54 AM

Three months ago, David A. Reckhow and other University of Massachusetts at Amherst researchers' efforts to learn about the compounds being formed as tiny amounts of prescription drugs slip into drinking water supplies received a major boost from Waters Corp., which allowed them to use one of its AquaAnalysis machines.

"The recent series of Globe Spotlight articles detailing the way Partners Healthcare uses its market power to exact high reimbursement rates from insurers - and to fund expansion into the suburbs - could simply be a Harvard Business School case study were the impact on the cost of healthcare not so great," a Globe editorial says. But "now that the state is committed to health coverage for all its residents, anything that pushes up overall costs is the state's business."

Email this article

Invalid email address
Invalid email address

Sending your article

Your article has been sent.

add your comment
Required
Required (will not be published)

This blogger might want to review your comment before posting it.

about white coat notes We post updates every weekday about the region's hospitals, labs and medical schools – covering everything from the latest research findings to what's on the minds of the innovative doctors, nurses and scientists who work here. Send news items and tips to whitecoat@globe.com

Contributors

blogger

Elizabeth Cooney is a former health reporter for the Worcester Telegram & Gazette, where she also was a business reporter and an editor. Earlier in her career, she edited medical books and journals at Little, Brown, and worked for Boston magazine.

Boston Globe Health and Science staff:

archives